首页> 外文OA文献 >Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

【2h】

Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

机译：预治疗中性粒细胞对淋巴细胞比例在伊替尼酸苏伊替尼衰竭后治疗晚期胃肠道肿瘤患者的预处理值

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Paweł Sobczuk; Paweł Teterycz; Iwona Lugowska; Anna Klimczak; Elżbieta Bylina; Anna Czarnecka; Hanna Kosela‑Paterczyk; Czesław Osuch; Joanna Streb; Piotr Rutkowski;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib [J] . AkiraSawaki, TatsuoKanda, YoshitoKomatsu, Gastroenterology research and practice . 2014,第1期

机译：伊马替尼和舒尼替尼治疗失败对晚期胃肠道间质瘤患者进行再挑战的影响
2. A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib. [J] . K N Ganjoo, V M Villalobos, A Kamaya, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第1期

机译：多唑帕尼对至少伊马替尼和舒尼替尼治疗失败的晚期胃肠道间质瘤（GIST）患者的多中心II期研究。
3. Sunitinib-a new approach following failure of imatinib in patients with advanced gastrointestinal stromal tumor [J] . Nature clinical practice. Oncology . 2007,第6期

机译：舒尼替尼-伊马替尼治疗晚期胃肠道间质瘤失败后的新方法
4. International classifications of gastrointestinal stromal tumor: a clue for adjuvant imatinib treatment [C] . Tzen Chin-Yuan International Gastric Cancer Congress . 2011

机译：胃肠道间质瘤的国际分类：佐剂伊马替尼治疗的线索
5. Molecular mechanisms of response in gastrointestinal stromal tumors treated with imatinib mesylate [D] . McAuliffe, John Christopher 2007

机译：甲磺酸伊马替尼治疗胃肠道间质瘤的分子机制
6. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure [O] . Paweł Sobczuk, Paweł Teterycz, Iwona Lugowska, -1

机译：伊马替尼治疗后接受舒尼替尼治疗的晚期胃肠道间质瘤患者中性粒细胞与淋巴细胞比例的预后价值
7. Relationship between efficacy of sunitinib and KIT mutation of patients with advanced gastrointestinal stromal tumors after failure of imatinib [O] . Fuming Xie, Weidong Xiao, Yahui Jiang, 2019

机译：伊替尼失效后户外胃肠基质肿瘤患者疗效与试剂盒突变的关系

Prognostic value of the pretreatment neutrophil‑to‑lymphocyte ratio in patients with advanced gastrointestinal stromal tumors treated with sunitinib after imatinib failure

著录项

引文网络

相似文献

相关主题

期刊订阅